Cargando…
Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia
BACKGROUND: Evidence for decreasing chloroquine (CQ) efficacy against Plasmodium vivax has been reported from many endemic countries in the world. In Ethiopia, P. vivax accounts for 40% of all malaria cases and CQ is the first-line drug for vivax malaria. Mutations in multidrug resistance 1 (pvmdr-1...
Autores principales: | Golassa, Lemu, Erko, Berhanu, Baliraine, Frederick N, Aseffa, Abraham, Swedberg, Göte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404130/ https://www.ncbi.nlm.nih.gov/pubmed/25889237 http://dx.doi.org/10.1186/s12936-015-0625-3 |
Ejemplares similares
-
Correction to: Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2018) -
Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2015) -
Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2013) -
Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
por: Golassa, Lemu, et al.
Publicado: (2015) -
High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)